| Catalog Number |
D134703 |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Code |
Stroke/CVA (1770)
|
| Date of Event |
06/05/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a patient underwent an atrial fibrillation (afib) - paroxysmal ablation and the patient experienced a cerebrovascular accident.The patient had a stroke during recovery post procedure.A magnetic resonance imaging (mri) was used to diagnose the stroke.The findings on brain scan showed acute infarct dorsal pons.It was reported that the patient remained in the hospital for monitoring and has recovered.Intervention included anticoagulants.Patient's symptoms mostly improved.During the procedure, there were twenty-two (22) pulsed field ablation (pfa) applications to the pulmonary veins only.The thermocool smarttouch sf catheter was used at the end of the procedure to complete a cavotricuspid isthmus (cti) line in the right atrium (4 radiofrequency (rf) applications).The activated clotting time (act) was therapeutic (365), and the patient was stable throughout the procedure.Pre-ablation thrombus check was performed.There was no evidence of char, thrombus/clot that were noted during the procedure.During the ablation, the patient was in sinus rhythm.The patient did not have any anatomical abnormalities.There were two catheter exchanges that occurred during the procedure with one transseptal puncture site performed.
|
| |
|
Additional Manufacturer Narrative
|
|
D4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.An analysis of the product could not be performed since a physical sample was not received for evaluation.An evaluation of the manufacturing record could not be performed as the required product identification number was not provided to complete the evaluation.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
On 03-jul-2025, additional information was received which indicated that the irrigation rate was 4 (ml/min).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.The manufacturer's reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information was received on 31- jul-2025.It was reported that ablation was done while in atrial fibrillation.Pre-clot screening was done with intracardiac echocardiography (ice) and protamine (50 u) was given after ablation.Activated clotting time (act) was >350 sec.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|